MONOPAR THERAPEUTICS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5981 USD | -8.13% |
|
-20.25% | +75.81% |
| May. 09 | Monopar Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Apr. 16 | Monopar Therapeutics Files Provisional Patent for New MNPR-101 Construct | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Neutral |
| Resistance | 0.7920 | 1.350 | 1.300 |
| Spread/Res. | -24.48% | -55.70% | -53.99% |
| Spread/Supp. | +1.27% | +106.74% | +99.30% |
| Support | 0.5906 | 0.2893 | 0.3001 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- MNPR Stock
- Charts Monopar Therapeutics Inc.
